No Detail Found!

Dose of Protamine for Heparin Reversal in CABG Surgery

Author(s)
Syed Ali Raza Ali Shah Department of Adult Cardiac Anesthesia, Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Syeda Sarah Naqvi Department of Physical Medicine and Rehabilitation, Combined Military Hospital/ National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Syed Muzaffar Hasan Kirmani Department of Adult Cardiac Anesthesia, Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Syed Aqeel Hussain Department of Adult Cardiac Anesthesia, Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Imran Bashir Malik Department of Adult Cardiac Anesthesia, Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Muhammad Umar Farooq Department of Adult Cardiac Anesthesia, Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To determine the dose of Protamine required for reversal of Heparin effect in Coronary Artery Bypass Grafting (CABG). Study Design: Quasi-experimental study. Place and Duration of Study: Adult Cardiac Surgery Unit, Armed Forces Institute of Cardiology/National Institute of Heart Diseases, Rawalpindi Pakistan, from May to Dec 2022. Methodology: Total 382 patients were included in this study through consecutive sampling and were divided into two groups (n=191 participants in each group). After induction of anesthesia, baseline Activated Clotting Time (ACT) was measured. About 300units/kg of unfractionated Heparin was given non-randomly before establishing Cardiopulmonary Bypass (CPB). After termination of CPB, Protamine was administered in doses of 1 mg/kg and 1.5 mg/kg to Group-A and Group-B respectively. Protamine was diluted in 20ml of saline, and administered at a rate of 100ml/hr. Once Protamine was administered, blood sample was taken after 5min for ACT measurement. If this ACT was within 10% of baseline, it was taken as sign for reversal of Heparin effect. Student t-test and Chi-square test were applied to compare the groups and level of significance taken was p<0.05. Results: Majority cases were males 287(75.1%), whereas 95(24.9%) were females. Statistically significant mean differences were noted between Cardiopulmonary Bypass (CPB) time, ACT after Protamine administration, and requirement for extra Protamine administration between two groups (p<0.05). However, no significant differences were noted between age, weight and ACT before Heparin administration (p>0.05). About 1mg/kg of Protamine reversed the Heparin effect in 116(60.7%) patients in Group-A, whereas 1.5mg/kg reversed the Heparin effect in 180(94.2%) cases in Group-B (p<0.001). Conclusion: Classical doses of 3mg/kg of Protamine in CABG patients may actually be exposing patients to higher than required doses of Protamine . Dose of 1mg/kg and 1.5mg/kg of Protamine was also found to be effective.
Publication Details
Page(s) 5567-5570
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: S3, Year: 2023

Request the full text from PASTIC

Keywords
Coronary Artery Bypass Grafting, Heparin, Protamine, Activated Clotting Time
0

Citations

0

Downloads

88

Views